An association study between catalase -262C >T gene polymorphism, sodium-lithium countertrasport activity, insulin resistance, blood lipid parameters and their response to atorvastatin, in Greek dyslipidaemic patients and normolipidaemic controls

Free Radical Research

Volumn 43, Issue 4, 2009, Pages 385-389

  Kosmidou, Maria ^a   Hatzitolios, Apostolos I ^a   Molyva, Dimitra ^b   Raikos, Nikolaos ^b   Savopoulos, Christos ^a   Daferera, Niki ^b   Kokkas, Vassileios ^b   Goulas, Antonis ^b  

^a AHEPA UNIVERSITY HOSPITAL   (Greece)

^b ARISTOTLE UNIVERSITY MEDICAL SCHOOL   (Greece)

Author keywords

Atorvastatin; Blood lipids; Catalase gene polymorphism; Insulin resistance; Sodium lithium countertransport

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; ATORVASTATIN; CATALASE; CHOLESTEROL; CYTOSINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LITHIUM; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SODIUM; THYMINE; TRIACYLGLYCEROL; ANTIPORTER; HEPTANOIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PYRROLE DERIVATIVE; SODIUM LITHIUM COUNTERTRANSPORTER; SODIUM-LITHIUM COUNTERTRANSPORTER;

ADULT; AGE; ALLELE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; DRUG RESPONSE; DYSLIPIDEMIA; FEMALE; GENDER; GENOTYPE; GREECE; HUMAN; HYPERTENSION; INSULIN RESISTANCE; ION TRANSPORT; LINEAR SYSTEM; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; SMOKING; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL; UNIVARIATE ANALYSIS; BLOOD; CASE CONTROL STUDY; DRUG EFFECT; ERYTHROCYTE; GENETICS; METABOLISM; MIDDLE AGED; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLELES; ANTIPORTERS; CASE-CONTROL STUDIES; CATALASE; DYSLIPIDEMIAS; ERYTHROCYTES; FEMALE; GREECE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INSULIN RESISTANCE; LINEAR MODELS; LIPIDS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PYRROLES; RETROSPECTIVE STUDIES;

EID: 67650124140     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.1080/10715760902783293     Document Type: Article

References (26)

1. West, IC, Rutherford, PA and Thomas, TH. (1998) Sodium-lithium countertransport: Physiology and function. J Hypertens, 16, pp. 3-13.
2. Morisson, AC, Boerwinkle, E., Turner, ST and Ferrell, RE. (2008) Regional association-based fine-mapping for sodium-lithium countertransport on chromosome 10. Am J Hypertens, 21, pp. 117-121.
3. Mead, P., Wilkinson, R. and Thomas, TH. (1999) Thiol protein defect in sodium-lithium countertransport in subset of essential hypertension. Hypertension, 34, pp. 1275-1280.
4. Wierzbicki, AS, Hardman, TC, Cheung, J., Lambert-Hammill, M., Patel, S., Morrish, Z., Lumb, PJ and Lant, AF. (2002) The apolipoprotein E2 allele modulates activity and maximal velocity of the sodium-lithium countertransporter. Am J Hypertens, 15, pp. 633-637.
5. Goulas, A., Kosmidou, M., Hatzitolios, AI, Raikos, N., Molyva, D., Savopoulos, C., Giannopoulos, S. and Fidani, L. (2008) An association study of sodium-lithium countertransport activity with glutathione S transferase (GST) T1 and GST M1 null polymorphisms in Greek dyslipidaemic patients and controls. Clin Chem Lab Med, 46, pp. 306-310.
6. Kosmidou, MS, Hatzitolios, AI, Adamidou, A., Giannopoulos, S., Raikos, N., Parharidis, G. and Milionis, HJ. (2008) Effects of atorvastatin on red-blood cell Na+/Li+ countertransport in hyperlipidemic patients with and without hypertension. Am J Hypertens, 21, pp. 303-309.
7. Mueller, S., Riedel, HD and Stremmel, W. (1997) Direct evidence for catalase as the predominant H2O2-removing enzyme in human erythrocytes. Blood, 90, pp. 4973-4978.
8. Forsberg, L., Lyrenas, L., de Faire, U. and Morgenstern, R. (2001) A common functional C-T substitution polymorphism in the promoter region of the human catalase gene influences transcription factor binding, reporter gene transcription and is correlated to blood catalase levels. Free Radic Biol Med, 30, pp. 500-505.
9. Ahn, J., Nowell, S., McCann, SE, Yu, J., Carter, L., Lang, NP, Kadlubar, FF, Ratnasinghe, LD and Ambrosone, CB. (2006) Associations between catalase phenotype and genotype: Modification by epidemiologic factors. Cancer Epidemiol Biomarkers Prev, 15, pp. 1217-1222.
10. Bastaki, M., Huen, K., Manzanillo, P., Chande, N., Chen, C., Balmes, JR, Tager, IB and Holland, N. (2006) Genotype-activity relationship for Mn-superoxide dismutase, glutathione peroxidase 1 and catalase in humans. Pharmacogenet Genomics, 16, pp. 279-286.
11. Perianayagam, MC, Liangos, O., Kolyada, AY, Wald, R., MacKinnon, RW, Li, L., Rao, M., Balakrishnan, VS, Bonventre, JV, Pereira, BJ and Jaber, BL. (2007) NADPH oxidase p22phox and catalase gene variants are associated with biomarkers of oxidative stress and adverse outcomes in acute renal failure. J Am Soc Nephrol, 18, pp. 255-263.
12. Nadif, R., Mintz, M., Jedlicka, A., Bertrand, J-P, Kleeberger, SR and Kauffmann, F. (2005) Association of CAT polymorphisms with catalase activity and exposure to environmental oxidative stimuli. Free Radic Res, 39, pp. 1345-1350.
13. Chistiakov, DA, Zotova, EV, Savostanov, KV, Bursa, TR, Galeev, IV, Strokov, IA and Nosikov, VV. (2006) The 262T > C promoter polymorphism of the catalase gene is associated with diabetic neuropathy in type 1 diabetic Russian patients. Diabetes Metab, 32, pp. 63-68.
14. Pask, R., Cooper, JD, Walker, NM, Nutland, S., Hutchings, J., Dunger, DB, Nejentsev, S. and Todd, JA. (2006) No evidence for a major effect of two common polymorphisms of the catalase gene in type 1 diabetes susceptibility. Diabetes Metab Res Rev, 22, pp. 356-360.
15. Göth, L., Lenkey, A. and Bigler, WN. (2001) Blood catalase deficiency and diabetes in Hungary. Diabetes Care, 10, pp. 1839-1840.
16. Tarnai, I., Csordas, M., Sukei, E., Shemirani, AH, Kaplar, M. and G(th, L. (2007) Effect of C111T polymorphism in exon 9 of the catalase gene on blood catalase activity in different types of diabetes mellitus. Free Radic Res, 41, pp. 806-811.
17. Vaccaro, O., Cuomo, V., Trevisan, M., Cirillo, M., Panarelli, W., Laurenzi, M., Mancini, M., Riccardi, G. and Gubbio Study Research Group (2005) Enhanced Na-Li countertransport: A marker of inherited susceptibility to type 2 diabetes. Int J Epidemiol, 34, pp. 1123-1128.
18. Dos Santos, KG, Canani, LH, Gross, JL, Tschiedel, B., Pires Souto, KE and Roisenberg, I. (2006) The catalase -262C/T promoter polymorphism and diabetic complications in Caucasians with type 2 diabetes. Dis Markers, 22, pp. 355-359.
19. Szelestei, T., Bahring, S., Wagner, Z., Aydin, A., Molnar, GA, Kocsis, B., Nagy, J. and Wittmann, I. (2005) Serum levels of L-arginine analogues and gluathione peroxidase and catalase gene variants in Type 2 diabetes mellitus patients. Diabet Med, 22, pp. 356-357.
20. Goulas, A., Kosmidou, M., Hatzitolios, AI, Molyva, D., Fidani, L., Giannopoulos, S. and Mirtsou, V. (2008) Glutathione S-transferase null and cholesteryl ester transfer protein TaqI B polymorphisms and lipid response to atorvastatin in Greek dyslipidaemic patients. Basic Clin Pharmacol Toxicol, 102, pp. 559-562.
21. Canessa, M., Adragna, N., Solomon, H., Connolly, T. and Tosteson, D. (1980) Increased sodium-lithium countertransport in red cells of patients with essential hypertension. N Engl J Med, 302, pp. 772-776.
22. Friedewald, WT, Levy, RI and Fredrickson, DS. (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18, pp. 499-502.
23. Houstis, N., Rosen, ED and Lander, ES. (2006) Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature, 440, pp. 944-948.
24. Keaney Jr, JF, Larson, MG and Vasan, RS. (2003) Obesity and systemic oxidative stress: Clinical corelates of oxidative stress in the Framingham study. Arterioscler Thromb Vasc Biol, 23, pp. 434-439.
25. D'souza, A., Kurien, BT, Rodgers, A., Shenoi, J., Kurono, S., Matsumoto, H., Hensley, K., Nath, SK and Scofield, RH (2008) Detection of catalase as a major protein target of the lipid peroxidation product 4-HNE and the lack of its genetic association as a risk factor in SLE. BMC, 9, p. 62.
26. Ho, YS, Xiong, Y., Ma, W., Spector, A. and Ho, DS. (2004) Mice lacking catalase develop normally but show differential sensitivity to oxidant tissue injury. J Biol Chem, 279, pp. 32804-32812.